DNA RNA and Cells

29 Jun 2010 InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
29 Jun 2010 Mirna Therapeutics Publishes Data Demonstrating In Vivo Proof of Concept for miR-34a microRNA Replacement Therapy in Cancer
28 Jun 2010 Quark Pharmaceutical's QPI-1007 Exhibits Neuroprotective Effects in Glaucoma Model
24 Jun 2010 t2cure’s Cellular Therapeutic Receives Orphan Drug Designation
23 Jun 2010 Prosensa and GlaxoSmithKline Initiate Development of Four Additional Products under Existing Alliance in Duchenne Muscular Dystrophy
23 Jun 2010 Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-Targeted Medicines for the Treatment of Cardiovascular Disease
22 Jun 2010 Sanofi-Aventis and Regulus Therapeutics Form Major Strategic Alliance on microRNA Therapeutics
22 Jun 2010 Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
22 Jun 2010 Pervasis Provides Update on Progress of Clinical Program Targeting Peripheral Arterial Disease
21 Jun 2010 OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
18 Jun 2010 Heart Bypass Patients Improve Significantly with Adult Stem Cell Infusion Reports TCA Cellular Therapy at ISSCR Meeting in San Francisco, CA
16 Jun 2010 SanBio Receives FDA Clearance to Initiate Cell Therapy Clinical Studies for Stroke Recovery
15 Jun 2010 TxCell Successfully Completes Preclinical Development of TX-RAD in Inflammatory Arthritis
09 Jun 2010 Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases
08 Jun 2010 Efficacy of MGN1703 DNA cancer medicine far exceeds
07 Jun 2010 XCell-Center GmbH Gets Approval by French Health Authorities to Conduct Clinical Trial with Stem Cells for Chronic Spinal Cord Injury
07 Jun 2010 Alnylam Presents Preliminary Phase I Data at American Society of Clinical Oncology (ASCO) Meeting for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers
07 Jun 2010 OncoGenex Pharmaceuticals Announces Final Results from Phase 1 Trial Evaluating OGX-427 as a Treatment for Solid Tumors
06 Jun 2010 Pooled Results of Early Endpoints from Phase 3 Trials of Genasense® in Advanced Melanoma Presented at ASCO
05 Jun 2010 Phase 3 Study Showed MACUGEN Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema
04 Jun 2010 Idera Pharmaceuticals Announces Publication of Preclinical Data on Cancer Immunotherapy with its Dual Agonist of Toll-like Receptors 7 and 8
04 Jun 2010 Biomet Announces Enrollment of First Subject into Its Investigational Device Exemption Clinical Trial for Critical Limb Ischemia Utilizing Autologous Concentrated Bone Marrow Aspirate
03 Jun 2010 AVI-4658 Demonstrates First Ever Reported Generation of Greater Than 50% Dystrophin-Positive Muscle Fibers in a Patient Following Systemic Administration in Duchenne Muscular Dystrophy; All Patients
01 Jun 2010 Tekmira Reports Complete Protection from Deadly Ebola Virus in Nonhuman Primates with SNALP-RNAi
30 May 2010 Targeted Genetics' Partner Celladon Corporation Reports Positive Phase 2 Clinical Trial Data at Heart Failure Association Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up